Pavel Hamet

Affiliation : Université de Montréal
Organization : Centre hospitalier universitaire de l’Université de Montréal (CHUM)
E-mail :
Web site

About Pavel Hamet

Pavel Hamet is the Canada Research Chair in Predictive Genomics. He is professor of Medicine at Université de Montréal, adjunct professor of Experimental Medicine at McGill University and visiting professor at the First Faculty of Medicine at Charles University in Prague. He is currently Chief of Gene Medicine Services, member of the Endocrinology Service, and Director of the Laboratory of Molecular Medicine at the CHUM. He is also Director of Medical affairs and principal investigator for CARTaGENE project. He serves on many national and international boards including the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research and he is President-elect of the International Society of Pathophysiology. He is also President and Chief Scientific Officer of Medpharmgene as well as President and Chief Executive Officer of Prognomix. He has received many honours, including the prestigious Wilder Penfield Award in 2001. In 2008, Dr Hamet was named as an Officer of the Ordre national du Québec and received the Okamoto Award by the Japan Vascular Disease Research Foundation. Since 2010, he is Associate Editor of Journal of Hypertension.

Ongoing competitions